Renaissance Capital logo

Universe Pharmaceuticals Priced, Nasdaq: UPC

Chinese pharmaceutical specializing in traditional Chinese medicine derivatives.

Industry: Health Care

Latest Trade: $2.17 -0.02 (-0.8%)

First Day Return: -5.0%

Return from IPO: -92.7%

Industry: Health Care

Traditional Chinese Medicine (TCM) is a comprehensive form of healthcare that has been widely adopted in China for more than 23 centuries. TCM rests upon the assumption that the human body is an ecosystem, embodying the fusion of Shen (psyche), Essence (soma), Qi, Moisture (body fluids), and Blood (tissue). Health in the context of TCM is more than just the absence of diseases, but to identify imbalance in human body and restore harmony. TCM is not only intended to cure diseases but to enhance the capacity for fulfillment, happiness and general well-being of people. We are a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration, and we currently produce 13 varieties of TCMD products, which are sold in approximately 249 cities of 30 provinces in China as of the date of this prospectus.
more less
IPO Data
IPO File Date 08/17/2020
Offer Price $5.00
Price Range $5.00 - $7.00
Offer Shares (mm) 5.0
Deal Size ($mm) $25
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/23/2021
Offer Price $5.00
Price Range $5.00 - $7.00
Offer Shares (mm) 5.0
Deal Size ($mm) $25
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Univest Securities
Company Data
Headquarters Jiangxi, China
Founded 1998
Employees 176
Website www.dzrzy.com

Universe Pharmaceuticals (UPC) Performance